Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Pregnancy and Childbirth
Published in: BMC Pregnancy and Childbirth 1/2018

Open Access 01-12-2018 | Research article

Task shifting in active management of the third stage of labor: a systematic review

Authors: Tessa M. Raams, Joyce L. Browne, Verena J. M. M. Festen-Schrier, Kerstin Klipstein-Grobusch, Marcus J. Rijken

Published in: BMC Pregnancy and Childbirth | Issue 1/2018

Login to get access

Abstract

Background

Active management of the third stage of labor (AMTSL) describes interventions with the common goal to prevent postpartum hemorrhage (PPH). In low- and middle-income countries, implementation of AMTSL is hampered by shortage of skilled birth attendants and a high percentage of home deliveries. Task shifting of specific AMTSL components to unskilled birth attendants or self-administration could be a strategy to increase access to potentially life-saving interventions. This study was designed to evaluate the effect, acceptance and safety of task shifting of specific aspects of AMTSL to unskilled birth attendants.

Methods

A systematic search was conducted in five databases in September 2015 to identify intervention studies of AMTSL implemented by unskilled birth attendants or pregnant women themselves. Quality of studies was evaluated with an adapted Cochrane Collaboration assessment tool.

Results

Of 2469 studies screened, 21 were included. All studies assessed implementation of uterotonics (misoprostol tablets or oxytocin injections), administered by community health workers (CHWs), auxiliary midwives, traditional birth attendants (TBAs) or self-administration at antenatal (home) visits or delivery. Task shifting for none of the other AMTSL components was reported. Task shifting of provision of uterotonics reduced the risk of PPH (RR 0.16 to 1) compared to standard care (13 studies, n = 15.197). The correct dose and timing was reported for 83.4 to 99.8% (5 studies, n = 6083) and 63 to 100% (9 studies, n = 8378) women respectively. Uterotonics were recommended to others by 80 to 99.7% (7 studies, n = 6445); 80 to 99.4% (5 studies, n = 2677) would use the drug at next delivery. Willingness to pay for uterotonics varied from 54.6 to 100% (7 studies, n = 6090).

Conclusion

Task shifting of AMTSL has thus far been evaluated for administration of uterotonics (misoprostol tablets and oxytocin injected by CHWs and auxiliary midwives) and resulted in reduction of PPH, high rates of appropriate use and satisfaction among users.
In order to increase AMTSL coverage in low-staffed health facilities, task shifting of uterine massage or postpartum tonus assessment to unskilled attendants or delivered women could be considered. Task shifting of controlled cord traction is currently not recommended.
Appendix
Available only for authorised users
Literature
1.
Sheldon WR, Blum J, Vogel JP, Souza JP, Gülmezoglu AM, Winikoff B. Postpartum haemorrhage management, risks, and maternal outcomes: findings from the World Health Organization multicountry survey on maternal and newborn health. BJOG. 2014;121(Suppl):5–13.CrossRefPubMed
2.
Breu F, Guggenbichler S, Wollmann J. World health statistics 2013. Vasa. 2013;168
3.
Lalonde A, Daviss BA, Acosta A, Herschderfer K. Postpartum hemorrhage today: ICM/FIGO initiative 2004-2006. Int J Gynaecol Obstet. 2006;94:243–53.CrossRefPubMed
4.
Dept. of Reproductive Health and Research. World Health Organization, dept. of reproductive health and research, World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: World Health Organization Press; 2012.
5.
Sibley LM, Spangler SA, Barry D, Tesfaye S, Desta BF, Gobezayehu AG. A regional comparison of distribution strategies and women’s awareness, receipt, and use of misoprostol to prevent postpartum hemorrhage in rural Amhara and Oromiya regions of Ethiopia. J Midwifery Womens Health. 2014;59(Suppl 1):S73–82.CrossRefPubMed
6.
Lalonde A. Prevention and treatment of postpartum hemorrhage in low-resource settings. Int J Gynaecol Obstet. 2012;117:108–18.CrossRefPubMed
7.
Geller SE, Adams MG, Kelly PJ, Kodkany BS, Derman RJ. Postpartum hemorrhage in resource-poor settings. Int J Gynaecol Obstet. 2006;92:202–11.CrossRefPubMed
8.
Gülmezoglu AM, Lumbiganon P, Landoulsi S, Widmer M, Abdel-aleem H, Festin M, et al. Active management of the third stage of labour with and without controlled cord traction : a randomised, controlled, non-inferiority trial. Lancet Elsevier Ltd. 2007;379:1721–7.CrossRef
9.
Hofmeyr GJ, Mshweshwe NT, Gülmezoglu AM. Controlled cord traction for the third stage of labour (review). Cochrane Database Syst Rev 2015, issue 1.Art. no. : CD008020.
10.
Sanghvi H, Ansari N, Prata NJV, Gibson H, Ehsan AT, Smith JM. Prevention of postpartum hemorrhage at home birth in Afghanistan. Int Fed Gynecol Obstet. 2010;108:276–81.CrossRef
11.
Walraven G, Blum J, Dampha Y, Sowe M, Morison L, Winikoff B, et al. Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial. BJOG An Int. J. Obstet. Gynaecol. 2005;112:1277–83.CrossRef
12.
Prata N, Bell S, Holston M, Quaiyum MA. Is attendant at delivery associated with the use of interventions to prevent postpartum hemorrhage at home births? The case of Bangladesh. BMC Pregnancy Childbirth. 2014;14:24.CrossRefPubMedPubMedCentral
13.
Smith JM, Baawo SD, Subah M, Sirtor-Gbassie V, Howe CJ, Ishola G, et al. Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia. BMC Pregnancy Childbirth. 2014;14:189.CrossRefPubMedPubMedCentral
14.
World Health Organization. Optimizing health worker roles to improve access to key maternal and newborn health interventions through task shifting. Geneva: World Health Organization; 2012.
15.
16.
Miller S, Lester F, Hensleigh P. Prevention and treatment of postpartum hemorrhage: new advances for low-resource settings. J Midwifery Womens. Health. 2004;49:283–92.CrossRefPubMed
17.
Mobeen N, Durocher J, Zuberi N, Jahan N, Blum J, Wasim S, et al. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial. BJOG. 2011;118:353–61.CrossRefPubMed
18.
Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2012;8:CD000494.
19.
Gulmezoglu AM, Villar J, Ngoc NT, Piaggio G, Carroli G, Adetoro L, et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet. 2001;358:689–95.CrossRefPubMed
20.
Oladapo OT, Fawole B, Blum J, Abalos E, Ot O, Fawole B, et al. Advance misoprostol distribution for preventing and treating postpartum haemorrhage ( review ). Cochrane Database Syst Rev. 2012;2:CD009336.
21.
Prata N, Passano P, Bell S, Rowen T, Potts M. New hope: community-based misoprostol use to prevent postpartum haemorrhage. Health Policy Plan. 2013;28:339–46.CrossRefPubMed
22.
Geller S, Carnahan L, Akosah E, Asare G, Agyemang R, Dickson R, et al. Community-based distribution of misoprostol to prevent postpartum haemorrhage at home births : results from operations research in rural Ghana. BJOG An Int J Obstet Gynaecol. 2014;121:319–26.CrossRef
23.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.CrossRefPubMedPubMedCentral
24.
World Health Organization. Making pregnancy safer : the critical role of the skilled attendant a joint statement by WHO, ICM and FIGO. Geneva: World Health Organization; 2004.
25.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://​handbook.​cochrane.​org.
26.
Field A. Discovering statistics using IBM SPSS statistics. Discov. Stat. Using IBM SPSS stat. hichester: Wiley; 2013. p. 297–321.
27.
Chandhiok N, Dhillon BS, Datey S, Mathur A, Saxena NC. Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India. Int J Gynecol Obstet. 2006;92:170–5.CrossRef
28.
Derman RJ, Kodkany BS, Goudar SS, Geller SE, Naik VA, Bellad MB, et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial. Lancet. 2006;368:1248–53.CrossRefPubMed
29.
Stanton CK, Newton S, Mullany LC, Cofie P, Tawiah Agyemang C, Adiibokah E, et al. Effect on postpartum hemorrhage of prophylactic Oxytocin (10 IU) by injection by community health officers in Ghana: a community-based. Cluster-Randomized Trial PLoS Med. 2013;10
30.
Ejembi C, Shittu O, Moran M, Adiri F, Oguntunde O, Saadatu B, et al. Community-level distribution of Misoprostol to prevent postpartum hemorrhage at home births in northern Nigeria. Afr J Reprod Health. 2014;18:166–75.PubMed
31.
Mir AM, Wajid A, Gull S. Helping rural women in Pakistan to prevent postpartum hemorrhage: a quasi experimental study. BMC Pregnancy Childbirth. 2012;12:120.CrossRefPubMedPubMedCentral
32.
Prata N, Gessessew A, Abraha AK, Holston M, Potts M. Prevention of postpartum hemorrhage: options for home births in rural Ethiopia. Afr J Reprod Health. 2009;13:87–95.PubMed
33.
Prata N, Ejembi C, Fraser A, Shittu O, Minkler M. Community mobilization to reduce postpartum hemorrhage in home births in northern Nigeria. Soc Sci Med Elsevier Ltd. 2012;74:1288–96.CrossRef
34.
Low LK, Bailey JM, Sacks E, Medina L, Piñeda HOL. Postpartum hemorrhage prevention: a case study in northern rural Honduras. J Midwifery Womens Health. 2008;53:e1–6.CrossRefPubMed
35.
Low LK, Bailey JM, Sacks E, Robles C, Medina L. Reduced postpartum hemorrhage after implementation of active management of the third stage of labor in rural Honduras. Int J Gynaecol Obstet. 2012;119:217–20.CrossRefPubMed
36.
Nasreen H-E, Nahar S, Al Mamun M, Afsana K, Byass P. Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it? Glob Health Action. 2011;4:1–11.
37.
Diadhiou M, Dieng T, Ortiz C, Mall I, Dione D, Sloan NL. Introduction of misoprostol for prevention of postpartum hemorrhage at the community level in Senegal. Int Fed Gynecol Obstet. 2011;115:251–5.CrossRef
38.
Prata N, Quaiyum MA, Passano P, Bell S, Bohl DD, Hossain S, et al. Training traditional birth attendants to use misoprostol and an absorbent delivery mat in home births. Soc Sci Med. 2012;75:2021–7.CrossRefPubMed
39.
Rajbhandari S, Hodgins S, Sanghvi H, McPherson R, Pradhan YV, Baqui AH. Expanding uterotonic protection following childbirth through community-based distribution of misoprostol: operations research study in Nepal. Int Fed Gynecol Obstet. 2010;108:282–8.CrossRef
40.
Smith JM, Dimiti A, Dwivedi V, Ochieng I, Dalaka M, Currie S, et al. Advance distribution of misoprostol for the prevention of postpartum hemorrhage in South Sudan. Int Fed Gynecol Obstet. 2014;127:183–8.CrossRef
41.
Smith HJ, Colvin CJ, Richards E, Roberson J, Sharma G, Thapa K, et al. Programmes for advance distribution of misoprostol to prevent post-partum haemorrhage: a rapid literature review of factors affecting implementation. Health Policy Plan. 2015:1–12.
42.
Smith JM, Gubin R, Holston MM, Fullerton J, Prata N. Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date. BMC Pregnancy Childbirth. 2013;13:44.CrossRefPubMedPubMedCentral
43.
Browne JL, Damale NK, Raams TM, Van der Linden EL, Maya ET, Doe R, et al. Uterine tonus assessment by midwives versus patient self-assessment in the active management of the third stage of labor (UTAMP): study protocol for a randomized controlled trial. Trials. 2015:1–6.
44.
Diop A, Daff B, Sow M, Blum J, Diagne M, Sloan NL, et al. Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial. Lancet Glob Health. 2016;4:e37–44. ACrossRefPubMed
Metadata
Title
Task shifting in active management of the third stage of labor: a systematic review
Authors
Tessa M. Raams
Joyce L. Browne
Verena J. M. M. Festen-Schrier
Kerstin Klipstein-Grobusch
Marcus J. Rijken
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2018
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-018-1677-5

Other articles of this Issue 1/2018

BMC Pregnancy and Childbirth 1/2018 Go to the issue

Research article

Prevalence of hypertensive disorders of pregnancy in Ethiopia: a systemic review and meta-analysis

Research article

Availability and affordability of priority life-saving medicines for under-five children in health facilities of Tigray region, northern Ethiopia

Research article

Nurturing maternal health in the midst of difficult life circumstances: a qualitative study of women and providers connected to a community-based perinatal program

Research article

Association between first caesarean delivery and adverse outcomes in subsequent pregnancy: a retrospective cohort study

Research article

Is anemia an independent risk factor for postpartum depression in women who have a cesarean section? - A prospective observational study

Research article

Epidemiology of unplanned out-of-hospital births attended by paramedics